Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)

CUSIP: 03237H101

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
109,540,561
Total 13F shares
81,690,006
Share change
+7,785,015
Total reported value
$523,632,250
Put/Call ratio
7.2%
Price per share
$6.41
Number of holders
131
Value change
+$57,316,535
Number of buys
67
Number of sells
74

Quarterly Holders Quick Answers

What is CUSIP 03237H101?
CUSIP 03237H101 identifies AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) as of Q2 2025

As of 30 Jun 2025, Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 81,690,006 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., PERCEPTIVE ADVISORS LLC, TCG Crossover Management, LLC, BlackRock, Inc., Point72 Asset Management, L.P., VANGUARD GROUP INC, Saturn V Capital Management LP, FMR LLC, Nantahala Capital Management, LLC, and 683 Capital Management, LLC. This page lists 131 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.